CV Sciences (CVSI) Amortizatization of Intangibles (2013 - 2026)
CV Sciences (CVSI) posted Amortizatization of Intangibles of $91000.0 for Q1 2026, down 28.35% sequentially from $127000.0 in Q4 2025, and down 38.93% YoY from $149000.0 in Q1 2025.
CV Sciences (CVSI) Amortizatization of Intangibles (2013 - 2026) Analysis & Trends
CV Sciences has reported Amortizatization of Intangibles for 8 years, with the latest figure at $91000.0 in Q1 2026.
- Quarterly Amortizatization of Intangibles fell 38.93% year-over-year to $91000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $455000.0 (up 27.09% YoY) and the FY2025 annual result came in at $513000.0, up 145.45% from the prior year.
- Amortizatization of Intangibles retreated to $91000.0 in Q1 2026 per CVSI's latest filing, from $127000.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $149000.0 in Q1 2025 and troughed at $91000.0 in Q1 2026.
- A 3-year average of $116142.9 and a median of $117000.0 in 2024 frame the typical range for Amortizatization of Intangibles.
- The sharpest annual moves came in 2025 and 2026: Amortizatization of Intangibles surged 38.04% in 2025, then plunged 38.93% in 2026.
- Over 3 years, Amortizatization of Intangibles stood at $92000.0 in 2024, then jumped by 38.04% to $127000.0 in 2025, then dropped by 28.35% to $91000.0 in 2026.
- According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $91000.0, $127000.0, and $107000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.92 Bn | 42.96 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.53 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.74 Bn | 30.06 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.22 Bn | 19.56 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.71 Bn | 17.83 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | 900,000.00 |
| 8 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | CV Sciences | 4.10 Mn | 3.84 Mn | 1.45 Mn | 40,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 91,000.00 |
| Mar 31, 2026 | 91,000.00 |
| Dec 31, 2025 | 127,000.00 |
| Dec 31, 2025 | 127,000.00 |
| Sep 30, 2025 | 107,000.00 |
| Sep 30, 2025 | 107,000.00 |
| Jun 30, 2025 | 130,000.00 |
| Jun 30, 2025 | 130,000.00 |
| Mar 31, 2025 | 149,000.00 |
| Mar 31, 2025 | 149,000.00 |
| Dec 31, 2024 | 92,000.00 |
| Dec 31, 2024 | 92,000.00 |
| Sep 30, 2024 | 117,000.00 |
| Sep 30, 2024 | 117,000.00 |
| Jun 30, 2018 | 37,000.00 |
| Jun 30, 2018 | 37,000.00 |
| Mar 31, 2018 | 13,000.00 |
| Mar 31, 2018 | 13,000.00 |
| Sep 30, 2017 | 10,988.00 |
| Sep 30, 2017 | 10,988.00 |